J B Segal

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs
    J B Segal
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Gen Intern Med 15:56-67. 2000
  2. ncbi request reprint Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials
    M R Miller
    Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Fam Pract 49:1033-46. 2000
  3. ncbi request reprint Autologous blood transfusion in the United States: clinical and nonclinical determinants of use
    J B Segal
    Department of Medicine, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Transfusion 41:1539-47. 2001
  4. ncbi request reprint Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews
    J A Krishnan
    Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, USA
    Respir Med 98:376-86. 2004
  5. pmc Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease
    R P Naik
    Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Thromb Haemost 12:2010-6. 2014
  6. ncbi request reprint Validating billing data for RBC transfusions: a brief report
    J B Segal
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institution, Baltimore, MD, USA
    Transfusion 41:530-3. 2001
  7. ncbi request reprint Prevalence of immune thrombocytopenia: analyses of administrative data
    J B Segal
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Thromb Haemost 4:2377-83. 2006

Collaborators

Detail Information

Publications7

  1. pmc Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs
    J B Segal
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Gen Intern Med 15:56-67. 2000
    ..This review summarizes the evidence regarding the efficacy of these medications...
  2. ncbi request reprint Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials
    M R Miller
    Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Fam Pract 49:1033-46. 2000
    ..Physicians have little evidentiary guidance for pharmacologic agent selection for atrial fibrillation (AF)...
  3. ncbi request reprint Autologous blood transfusion in the United States: clinical and nonclinical determinants of use
    J B Segal
    Department of Medicine, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Transfusion 41:1539-47. 2001
    ..The use of autologous blood is not well quantified. This study aimed at identifying the frequency and determinants of use of autologous transfusion in the United States...
  4. ncbi request reprint Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews
    J A Krishnan
    Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, USA
    Respir Med 98:376-86. 2004
    ..To evaluate the methodology and cumulative evidence presented in systematic reviews of clinical trials comparing low-molecular-weight heparin (LMWH) with unfractionated heparin (UFH) for the treatment of venous thromboembolism...
  5. pmc Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease
    R P Naik
    Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Thromb Haemost 12:2010-6. 2014
    ..Venous thromboembolism (VTE) has been recently recognized as a complication of sickle cell disease (SCD); however, the incidence of VTE in SCD is unknown...
  6. ncbi request reprint Validating billing data for RBC transfusions: a brief report
    J B Segal
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institution, Baltimore, MD, USA
    Transfusion 41:530-3. 2001
    ..035) than billed patients. CONCLUSIONS: The billing for RBC transfusion in one large institution is reassuringly valid. The specificity is excellent, and the sensitivity is higher than that seen in other studies of coding validity...
  7. ncbi request reprint Prevalence of immune thrombocytopenia: analyses of administrative data
    J B Segal
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Thromb Haemost 4:2377-83. 2006
    ..The prevalence of immune thrombocytopenic purpura (ITP) in the USA is unknown. The paucity of data makes clinical trial design and resource allocation challenging...